Abeona Therapeutics
Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company’s robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery.
Domain
abeonatherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$75.0M
Founded
1988
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Abeona Therapeutics use?+
Abeona Therapeutics uses 21 technologies including Google Analytics, Google Tag Manager, OneTrust.
What industry is Abeona Therapeutics in?+
Abeona Therapeutics operates in the Biotechnology industry.
Where is Abeona Therapeutics based?+
Abeona Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026